
HealthEquity, Inc.: updates and filings
Price
$94.75
November 20, 2026Market cap $8.0B
What Ploutos Investor adds for HealthEquity
Part of Ploutos Investor, €9.99 a month
- The full history: 14 fiscal years, from FY2013
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Aug 27, 2026next Nov 27, 2026
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 9, 2026Officer or director changeForm8-K
- Oct 9, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 30, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 27, 2026Shares registered for employeesFormS-8
- Aug 27, 2026Quarterly reportfor the period to Jul 31, 2026Form10-Q
- Aug 27, 2026Results of operationsForm8-K
- Jul 31, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 26, 2026Shares registered for employeesFormS-8
- Jun 26, 2026Shareholder voteForm8-K
- May 28, 2026Quarterly reportfor the period to Apr 30, 2026Form10-Q
- May 28, 2026Results of operationsForm8-K
- May 13, 2026Annual report to shareholdersfor the period to Jan 31, 2026FormARS
- May 13, 2026Additional annual meeting materialFormDEFA14A
- May 13, 2026Annual meeting proxy statementFormDEF 14A
- May 8, 2026Officer or director changeForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 6, 2026Officer or director changeForm8-K
- Mar 30, 2026Officer or director change, Regulation FD disclosureForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 17, 2026Annual reportfor the period to Jan 31, 2026Form10-K
- Mar 17, 2026Results of operationsForm8-K
- Feb 17, 2026Results of operationsForm8-K
- Feb 5, 2026Letter from the SECFormUPLOAD
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 9, 2026 | 8-K | Officer or director change | Document |
| Oct 9, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 30, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 27, 2026 | S-8 | Shares registered for employees | Document |
| Aug 27, 2026 | 10-Q | Quarterly reportfor the period to Jul 31, 2026 | Document |
| Aug 27, 2026 | 8-K | Results of operations | Document |
| Jul 31, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 26, 2026 | S-8 | Shares registered for employees | Document |
| Jun 26, 2026 | 8-K | Shareholder vote | Document |
| May 28, 2026 | 10-Q | Quarterly reportfor the period to Apr 30, 2026 | Document |
| May 28, 2026 | 8-K | Results of operations | Document |
| May 13, 2026 | ARS | Annual report to shareholdersfor the period to Jan 31, 2026 | Document |
| May 13, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 13, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 8, 2026 | 8-K | Officer or director change | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 6, 2026 | 8-K | Officer or director change | Document |
| Mar 30, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 17, 2026 | 10-K | Annual reportfor the period to Jan 31, 2026 | Document |
| Mar 17, 2026 | 8-K | Results of operations | Document |
| Feb 17, 2026 | 8-K | Results of operations | Document |
| Feb 5, 2026 | UPLOAD | Letter from the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 22, 2008.
The full analysis
What do HealthEquity's filings show?
The filings are where every one of HealthEquity's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.